Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Alzheimer's Disease

  Free Subscription


1 Acta Neuropathol
1 Ann Neurol
1 BMC Geriatr
3 Brain
1 Curr Opin Neurol
1 Dement Geriatr Cogn Disord
1 Exp Gerontol
13 J Alzheimers Dis
1 Nat Rev Neurol
5 Neurobiol Aging
1 Neurochem Res
3 Neurology
2 Rev Neurol (Paris)

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Neuropathol

  1. BARON T, Arsac JN, Verchere J, Tlili H, et al
    Co-expression of APP/PS1 disrupts the distribution of brain lesions in a synucleinopathy transgenic mouse model (M83).
    Acta Neuropathol. 2022;143:527-529.

    Ann Neurol

  2. MEYER PF, Ashton NJ, Karikari TK, Strikwerda-Brown C, et al
    Plasma p-tau231, p-tau181, PET biomarkers and cognitive change in older adults.
    Ann Neurol. 2022 Jan 27. doi: 10.1002/ana.26308.
    PubMed         Abstract available

    BMC Geriatr

  3. GREEN RK, Shah MN, Clark LR, Batt RJ, et al
    Comparing emergency department use among individuals with varying levels of cognitive impairment.
    BMC Geriatr. 2022;22:382.
    PubMed         Abstract available


  4. LEGAZ A, Abrevaya S, Dottori M, Gonzalez Campo C, et al
    Multimodal mechanisms of human socially reinforced learning across neurodegenerative diseases.
    Brain. 2022;145:1052-1068.
    PubMed         Abstract available

  5. VROMEN EM, de Boer SCM, Teunissen CE, Rozemuller A, et al
    Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology study.
    Brain. 2022 May 2. pii: 6576655. doi: 10.1093.
    PubMed         Abstract available

  6. BARKER MS, Gottesman RT, Manoochehri M, Chapman S, et al
    Proposed research criteria for prodromal behavioural variant frontotemporal dementia.
    Brain. 2022;145:1079-1097.
    PubMed         Abstract available

    Curr Opin Neurol

  7. MALATT C, Tagliati M
    The role of the locus coeruleus/norepinephrine system in the pathogenesis of neurodegenerative disorders: An update.
    Curr Opin Neurol. 2022;35:220-229.
    PubMed         Abstract available

    Dement Geriatr Cogn Disord

  8. GERARDS M, Schild AK, Meiberth D, Rostamzadeh A, et al
    Alzheimer's Disease Plasma Biomarkers Distinguish Clinical Diagnostic Groups in Memory Clinic Patients.
    Dement Geriatr Cogn Disord. 2022 May 3:1-11. doi: 10.1159/000524390.
    PubMed         Abstract available

    Exp Gerontol

  9. REISS AB, Ahmed S, Dayaramani C, Glass AD, et al
    The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment.
    Exp Gerontol. 2022 May 1:111828. doi: 10.1016/j.exger.2022.111828.
    PubMed         Abstract available

    J Alzheimers Dis

  10. GRAHAM A, Livingston G, Purnell L, Huntley J, et al
    Mild Traumatic Brain Injuries and Future Risk of Developing Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220069. doi: 10.3233/JAD-220069.
    PubMed         Abstract available

  11. DIAS IHK, Shokr H, Shephard F, Chakrabarti L, et al
    Oxysterols and Oxysterol Sulfates in Alzheimer's Disease Brain and Cerebrospinal Fluid.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD220083. doi: 10.3233/JAD-220083.
    PubMed         Abstract available

  12. LENG F, Zhan Z, Sun Y, Liu F, et al
    Cerebrospinal Fluid sTREM2 Has Paradoxical Association with Brain Structural Damage Rate in Early- and Late-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD220102. doi: 10.3233/JAD-220102.
    PubMed         Abstract available

  13. LOBUE C, Kelley BJ, Hart J, Helphrey J, et al
    Mild Traumatic Brain Injury is Related to Elevated Cerebrospinal Fluid Tau in Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220112. doi: 10.3233/JAD-220112.
    PubMed         Abstract available

  14. BOSE A, Dutta M, Dash NS, Nandi R, et al
    Importance of Task Selection for Connected Speech Analysis in Patients with Alzheimer's Disease from an Ethnically Diverse Sample.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220166. doi: 10.3233/JAD-220166.
    PubMed         Abstract available

  15. DONG L, Liu C, Sha L, Mao C, et al
    PSEN2 Mutation Spectrum and Novel Functionally Validated Mutations in Alzheimer's Disease: Data from PUMCH Dementia Cohort.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220194. doi: 10.3233/JAD-220194.
    PubMed         Abstract available

    Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance.
    J Alzheimers Dis. 2022 Apr 23. pii: JAD215730. doi: 10.3233/JAD-215730.
    PubMed         Abstract available

  17. SALEHIPOUR A, Bagheri M, Sabahi M, Dolatshahi M, et al
    Combination Therapy in Alzheimer's Disease: Is It Time?
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215680. doi: 10.3233/JAD-215680.
    PubMed         Abstract available

  18. CHEN D, Yi F, Qin Y, Zhang J, et al
    A Stacking Framework for Multi-Classification of Alzheimer's Disease Using Neuroimaging and Clinical Features.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215654. doi: 10.3233/JAD-215654.
    PubMed         Abstract available

  19. LLAMAS-RODRIGUEZ J, Oltmer J, Greve DN, Williams E, et al
    Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD215567. doi: 10.3233/JAD-215567.
    PubMed         Abstract available

  20. SALAZAR CR, Ritchie M, Gillen DL, Grill JD, et al
    Strategies Associated with Retaining Participants in the Longitudinal National Alzheimer's Coordinating Center Uniform Data Set Study.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD215537. doi: 10.3233/JAD-215537.
    PubMed         Abstract available

  21. KIM H, Levine A, Cohen D, Gehrman P, et al
    The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.
    J Alzheimers Dis. 2022 Apr 28. pii: JAD215417. doi: 10.3233/JAD-215417.
    PubMed         Abstract available

  22. TONGSIRI S, Levkoff S, Gallagher-Thompson D, Teri L, et al
    Cultural Adaptation of the Reducing Disability in Alzheimer's Disease (RDAD) Protocol for an Intervention to Reduce Behavioral and Psychological Symptoms of Dementia in Thailand.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215253. doi: 10.3233/JAD-215253.
    PubMed         Abstract available


    First Donepezil Transdermal Patch Approved for Alzheimer Disease.
    JAMA. 2022;327:1642.

    Nat Rev Neurol

  24. FYFE I
    Influence of amyloid-beta on tau spread in Alzheimer disease explained.
    Nat Rev Neurol. 2022 May 4. pii: 10.1038/s41582-022-00667.

    Neurobiol Aging

  25. BABILONI C, Lorenzo I, Lizio R, Lopez S, et al
    Reactivity of posterior cortical electroencephalographic alpha rhythms during eyes opening in cognitively intact older adults and patients with dementia due to Alzheimer's and Lewy body diseases.
    Neurobiol Aging. 2022;115:88-108.
    PubMed         Abstract available

  26. KIM J, Jung SH, Choe YS, Kim S, et al
    Ethnic differences in the frequency of beta-amyloid deposition in cognitively normal individuals.
    Neurobiol Aging. 2022;114:27-37.
    PubMed         Abstract available

  27. PALMER JA, Kaufman CS, Vidoni ED, Honea RA, et al
    Cerebrovascular response to exercise interacts with individual genotype and amyloid-beta deposition to influence response inhibition with aging.
    Neurobiol Aging. 2022;114:15-26.
    PubMed         Abstract available

  28. KIM SJ, Woo SY, Kim YJ, Jang H, et al
    Development of prediction models for distinguishable cognitive trajectories in patients with amyloid positive mild cognitive impairment.
    Neurobiol Aging. 2022;114:84-93.
    PubMed         Abstract available

  29. HUTTULA S, Vayrynen H, Helisalmi S, Kytovuori L, et al
    NDUFA1 p.Gly32Arg variant in early-onset dementia.
    Neurobiol Aging. 2022;114:113-116.
    PubMed         Abstract available

    Neurochem Res

  30. THENMOZHI AJ, Raja TRW, Janakiraman U, Manivasagam T, et al
    Correction to: Neuroprotective Effect of Hesperidin on Aluminium Chloride Induced Alzheimer's Disease in Wistar Rats.
    Neurochem Res. 2022 May 4. pii: 10.1007/s11064-022-03616.


  31. CHO S, Quilico Cousins KA, Shellikeri S, Ash S, et al
    Lexical and Acoustic Speech Features Relating to Alzheimer Disease Pathology.
    Neurology. 2022 Apr 29. pii: WNL.0000000000200581.
    PubMed         Abstract available

  32. BEYDOUN MA, Beydoun HA, Fanelli-Kuczmarski MT, Weiss J, et al
    Association of Serum Antioxidant Vitamins and Carotenoids With Incident Alzheimer Disease and All-Cause Dementia Among US Adults.
    Neurology. 2022 May 4. pii: WNL.0000000000200289.
    PubMed         Abstract available

  33. AGOSTA F, Filippi M
    Natural Speech Analysis: A Window Into Alzheimer Disease Phenotypes.
    Neurology. 2022 May 4. pii: WNL.0000000000200843.

    Rev Neurol (Paris)

    Therapeutic news in Alzheimer's disease: Soon a disease-modifying therapy?
    Rev Neurol (Paris). 2022 Apr 27. pii: S0035-3787(22)00550.
    PubMed         Abstract available

  35. SCHRAMM C, Wallon D, Nicolas G, Charbonnier C, et al
    What contribution can genetics make to predict the risk of Alzheimer's disease?
    Rev Neurol (Paris). 2022 Apr 28. pii: S0035-3787(22)00553.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.